Drugmaker Merck & Co. has spurt of new medicine launches, mostly outside United States

Merck launching numerous drugs around the world

Merck & Co. is enjoying a spurt of new drug launches, partly due to its $41 billion November acquisition of New Jersey neighbor Schering-Plough Corp. Some have been on the market in the United States for a while, including blockbuster diabetes medicine Januvia, and are now being launched in other countries.

DRUG NAME  CONDITION/USE                   WHERE IT’S LAUNCHING

Asmanex  Asthma                          Japan

Bridion  Reversal of anesthesia          30 countries outside the U.S.

Elonva  Fertility treatment             European Union

Januvia  Type 2 diabetes                 Japan

Remeron  Depression                      Japan

Saflutan  Glaucoma                        European Union

Saphris  Schizophrenia/bipolar disorder  United States

Simponi  Immune disorders                5 countries

Tredaptive  Hardening of the arteries       27 countries outside the U.S. 

Data as of March 1. Source: Merck & Co.